RARRES2 and chronic obstructive pulmonary disease: A retrospective study in COPD patients [74] showed that treatment with salmeterol/fluticasone propionate combined with aerosol inhalation significantly reduced plasma levels of IL-8 and C-reactive protein in COPD patients and that plasma chemerin levels were lower after treatment than before.